NEW HAVEN, Conn., March 5, 2010 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer, will be presenting a company overview at the upcoming investor conferences:
- The Cowen & Company 30th Annual Healthcare Conference on Wednesday, March 10, 2010 at 11:00 a.m. ET at the Marriott Copley Place in Boston;
- The Wall Street Forum 21st Annual Analyst Conference on Friday, March 12, 2010 at 12:05 p.m. ET at the University Club in New York City; and
- Roth Capital Partners 22nd Annual OC Growth Stock Conference on Monday, March 15, 2010 at 12:00 p.m. PT at The Ritz Carlton in Laguna Niguel, California.
The live audio broadcasts and the subsequent archived webcasts of the Company's presentations will be available on the Company's website, http://www.achillion.com, under the "News Center" section. The audio recording will be archived there for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary.
About Achillion
Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease –hepatitis C, resistant bacterial infections and HIV. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000. ACHN-G